国际标准期刊号: 2576-3881

细胞因子生物学杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

The Role of Cytokines and the Drugs that Block them in Acute Pancreatitis

Luis Escobar

Acute pancreatitis is an inflammation that first affects the pancreatic gland but can progress to other organs.Pathophysiological pathways connected to the systemic inflammatory response, with cytokines and oxidative stress as two of their key constituents, mediate the development of severe acute pancreatitis. The primary source of cytokines are activated leukocytes. The majority of the side effects of the systemic inflammatory response syndrome are initiated and spread by interleukin 1ß and tumour necrosis factor alpha (TNF-), which amplifies the inflammatory response. Numerous cell types create cytokines, which are low molecular weight soluble proteins, in response to stress or injury as a way of cell-to-cell communication. The primary source of cytokines, which are consequently crucial elements of the inflammatory cascade, is activated leukocytes. Interleukin 1ß (IL-1ß) and tumour necrosis factor alpha (TNF-) are two of the main members of the cytokine inflammatory family that trigger both the expression of their own cytokines as well as the expression of other cytokines, amplifying the inflammatory response. Nearly all of the effects of the systemic inflammatory response syndrome are started by and spread by these cytokines. Comparatively to those from patients without systemic problems, the monocytes from individuals with acute pancreatitis produce more TNF-, IL-6, and IL-8.